OTC DRUGS OF ABUSE TEST GUIDANCE RECOMMENDS CONSUMER STUDY WITH POST-TESTING SURVEY; DRAFT DOCUMENT SLATED FOR FDA PANEL REVIEW SEPT. 25
This article was originally published in The Gray Sheet
Executive Summary
An FDA guidance on over-the-counter test kits for drugs of abuse is scheduled for review by the agency's Clinical Chemistry and Clinical Toxicology Devices Panel on Sept. 25 in Bethesda, Maryland.